Community Schedule

You are currently viewing April 2023

1 results showing for: 'octreotide long-acting'

Octreotide long-acting

Medsafe Data Sheets

New Zealand Formulary.

Hospital Medicines List.

- Special Authority SA2072 -- Retail pharmacy

Inj depot 10 mg prefilled syringe
- Brand Fully subsidised brand. Sandostatin LAR
- Pharmacode2150832
- Subsidy $1772.50
- Measure / Qty per 1
- Brand Fully subsidised brand. Octreotide Depot Teva
- Pharmacode2615320
- Subsidy $439.97
- Measure / Qty per 1
(Sandostatin LAR Inj depot 10 mg prefilled syringe to be delisted 01 March 2022)

Inj depot 20 mg prefilled syringe
- Brand Fully subsidised brand. Sandostatin LAR
- Pharmacode2150840
- Subsidy $2358.75
- Measure / Qty per 1
- Brand Fully subsidised brand. Octreotide Depot Teva
- Pharmacode2615339
- Subsidy $647.03
- Measure / Qty per 1
(Sandostatin LAR Inj depot 20 mg prefilled syringe to be delisted 01 March 2022)

Inj depot 30 mg prefilled syringe
- Brand Fully subsidised brand. Sandostatin LAR
- Pharmacode2150859
- Subsidy $2951.25
- Measure / Qty per 1
- Brand Fully subsidised brand. Octreotide Depot Teva
- Pharmacode2615347
- Subsidy $718.55
- Measure / Qty per 1
(Sandostatin LAR Inj depot 30 mg prefilled syringe to be delisted 01 March 2022)

SA2072 - Octreotide long-acting

For GnRH ANALOGUES – refer to HORMONE PREPARATIONS, Trophic Hormones, page 84

Rectangle page icon symoblising a PDF. PDF
A tick icon. Fully subsidised
An oval with the number 29 in it. Unapproved medicine under Section 29
An asterisk symbol. 3 or 6 months should be dispensed at once
Two duplicate pages icon. Click to copy
A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
OP Original pack
Sole Subsidised Supply